Contact PI/Project LeaderJONES, REESE T. Other PIs
Awardee OrganizationUNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Description
Abstract Text
DESCRIPTION (provided by applicant): This Core Support Center Grant (P30) application requests continued support for an analytic and synthetic chemistry laboratory and administrative shared core infrastructure. The participating, currently funded, constituent projects continue research programs with human laboratory and treatment clinic studies of the clinical pharmacology of abused drugs, pharmacotherapies and other treatment strategies to treat drug abuse and addictions. Drugs of interest to participating projects and assays available include nicotine and its metabolites, cocaine, methamphetamine and other phenethylamines, alcohol, MDMA, ephedra alkaloids, caffeine, gamma hydroxybutyrate (GHB), salvinorin, adenosine, and neurosteroids, and opiates. Analytical methods have been developed and validated in the core analytic laboratory to support studies with these drugs. Other new assays and labeled (deuterated) compounds will be made available to the associated research projects as needed. Disciplines represented by the participating projects and investigators include psychiatry, clinical psychology, neurology, general internal medicine, cardiology and clinical pharmacology, psychopharmacology, toxicology, genetics, pediatrics, pharmacy, organic, medicinal and analytical chemistry, and statistics. Our aims are: (1) to provide a state-of-the-art well equipped and staffed, analytical and synthetic chemistry laboratory resource for the participating projects of drug abuse researchers at UCSF and at other institutions. (2) To provide administrative support for manuscript preparation, IRB and related regulatory documents, grants management, and other research administrative services of value participating projects. (3) To provide statistical consulting services regarding study design and data analysis strategies, particularly optimal pharmacokinetic analysis to participating projects. The overall objective is to provide sophisticated analytic laboratory resources with stability of support together with adequate administrative support responsive to the needs of individual funded constituent scientific projects as those projects change and evolve. This facility is a cost-effective shared laboratory resource that enhances and extends research possibilities of investigators currently funded by NIH or other federal or nonfederal sources to further our understanding of human psychoactive drug use, abuse and addiction, its health consequences and its treatment management.
Public Health Relevance Statement
PUBLIC HEALTH RELEVANCE: When researching the causes of drug addictions, measuring the health and other consequences of drug use, and searching for effective treatments for addicted people, measures of the amount of drug actually in a person's body are often important. This grant supports a state of the art analytic chemistry laboratory that provides, to a large number of research groups, innovative, sensitive, reliable and cost effective measures of commonly used drugs like nicotine, methamphetamine, opiates and other addicting drugs.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AdenosineAlcoholsAlkaloidsAnalytical ChemistryBiological AssayCaffeineCancer Grant Supplements (P30)ClinicClinical PharmacologyClinical PsychologyClinical ResearchCocaineConsultData AnalysesDisciplineDrug AddictionDrug KineticsDrug abuseDrug usageEphedraFundingGrantHealthHumanIndividualInstitutionInstitutional Review BoardsInternal MedicineLabelLaboratoriesManuscriptsMeasuresMethamphetamineNeurologyNicotineOpiatesOrganic ChemistryPediatricsPersonsPharmaceutical ChemistryPharmaceutical PreparationsPharmacy facilityPhenethylaminesPreparationPsychiatryPsychopharmacologyPsychotropic DrugsRequest for ApplicationsResearchResearch DesignResearch InfrastructureResearch PersonnelResearch Project GrantsResourcesServicesSourceSynthesis ChemistryToxicogeneticsUnited States National Institutes of Healthaddictionanalytical methodcost effectivedrug abuse chemotherapydrug addictecstasyeffective therapygamma hydroxybutyrateheart pharmacologyinnovationinterestneurosteroidsprogramsstatisticstreatment strategy
No Sub Projects information available for 5P30DA012393-13
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P30DA012393-13
Patents
No Patents information available for 5P30DA012393-13
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P30DA012393-13
Clinical Studies
No Clinical Studies information available for 5P30DA012393-13
News and More
Related News Releases
No news release information available for 5P30DA012393-13
History
No Historical information available for 5P30DA012393-13
Similar Projects
No Similar Projects information available for 5P30DA012393-13